Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey W Tyner

Showing results (11-20 of 209) with videos related to

Pageof 21
Sort By:
Haematologica|June 3, 2020
Keys to drug sensitivity from updated functional work flowsStephen E Kurtz, Jeffrey W Tyner
Blood|December 29, 2016
Genomics of chronic neutrophilic leukemiaJulia E Maxson, Jeffrey W Tyner
Blood|May 19, 2012
JAK2 V617F down-modulates MPLAngela G Fleischman, Jeffrey W Tyner
Bio-Protocol|July 26, 2016
Immunoprecipitation of ROR1Vincent T Bicocca, Jeffrey W Tyner
Blood|November 30, 2013
Causal role for JAK2 V617F in thrombosisAngela G Fleischman, Jeffrey W Tyner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapiesKim-Hien T Dao, Jeffrey W Tyner
Hematology. American Society of Hematology. Education Program|December 6, 2015
What's different about atypical CML and chronic neutrophilic leukemia?Kim-Hien T Dao, Jeffrey W Tyner
Current Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason Gotlib
Nature Reviews. Cancer|June 24, 2017
Turning the tide in myelodysplastic/myeloproliferative neoplasmsMichael W N Deininger, Jeffrey W Tyner, Eric Solary
Best Practice & Research. Clinical Haematology|November 30, 2019
What do functional genomics tell us about pathogenesis of AML?Jeffrey W Tyner, Daniel Bottomly, Beth Wilmot, et al.
Pageof 21

Showing results (11-20 of 209) with videos related to

Sort By:
Pageof 21
Haematologica|June 3, 2020
Keys to drug sensitivity from updated functional work flowsStephen E Kurtz, Jeffrey W Tyner
Blood|December 29, 2016
Genomics of chronic neutrophilic leukemiaJulia E Maxson, Jeffrey W Tyner
Blood|May 19, 2012
JAK2 V617F down-modulates MPLAngela G Fleischman, Jeffrey W Tyner
Bio-Protocol|July 26, 2016
Immunoprecipitation of ROR1Vincent T Bicocca, Jeffrey W Tyner
Blood|November 30, 2013
Causal role for JAK2 V617F in thrombosisAngela G Fleischman, Jeffrey W Tyner
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2013
Next-generation medicine: combining BCR-ABL and Hedgehog-targeted therapiesKim-Hien T Dao, Jeffrey W Tyner
Hematology. American Society of Hematology. Education Program|December 6, 2015
What's different about atypical CML and chronic neutrophilic leukemia?Kim-Hien T Dao, Jeffrey W Tyner
Current Hematologic Malignancy Reports|October 7, 2017
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid LeukemiaKim-Hien T Dao, Jeffrey W Tyner, Jason Gotlib
Nature Reviews. Cancer|June 24, 2017
Turning the tide in myelodysplastic/myeloproliferative neoplasmsMichael W N Deininger, Jeffrey W Tyner, Eric Solary
Best Practice & Research. Clinical Haematology|November 30, 2019
What do functional genomics tell us about pathogenesis of AML?Jeffrey W Tyner, Daniel Bottomly, Beth Wilmot, et al.
Pageof 21